[{"x_label":"Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Relapse Tumors, N = 75)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":75,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Lymphoblastic Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000220","MONDO":"MONDO_0004967","GTEx_tissue_subgroup_UBERON":"","TPM_mean":18.51,"TPM_sd":15.11,"TPM_min":0.93,"TPM_25th_percentile":6.78,"TPM_median":14.09,"TPM_75th_percentile":27.95,"TPM_max":68.29},{"x_label":"Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Relapse Tumors, N = 42)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":42,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Myeloid Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000222","MONDO":"MONDO_0018874","GTEx_tissue_subgroup_UBERON":"","TPM_mean":13.46,"TPM_sd":11.04,"TPM_min":0.21,"TPM_25th_percentile":7.3,"TPM_median":10.52,"TPM_75th_percentile":18.22,"TPM_max":64.48},{"x_label":"Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Adamantinomatous Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000069","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.75,"TPM_sd":2.09,"TPM_min":4.06,"TPM_25th_percentile":5.53,"TPM_median":6.48,"TPM_75th_percentile":8.34,"TPM_max":11.37},{"x_label":"Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 14)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":14,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Atypical Teratoid Rhabdoid Tumor","GTEx_tissue_subgroup":"","EFO":"EFO_1002008","MONDO":"MONDO_0020560","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.6,"TPM_sd":4.54,"TPM_min":3,"TPM_25th_percentile":4.73,"TPM_median":6.6,"TPM_75th_percentile":8.86,"TPM_max":17.5},{"x_label":"Chordoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Chordoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0008978","MONDO":"MONDO_0008978","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.1,"TPM_sd":2.97,"TPM_min":6.13,"TPM_25th_percentile":6.39,"TPM_median":6.66,"TPM_75th_percentile":9.09,"TPM_max":11.51},{"x_label":"Choroid plexus carcinoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 5)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Choroid plexus carcinoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016718","MONDO":"MONDO_0016718","GTEx_tissue_subgroup_UBERON":"","TPM_mean":28.52,"TPM_sd":40.07,"TPM_min":1.91,"TPM_25th_percentile":2.1,"TPM_median":7.13,"TPM_75th_percentile":35.84,"TPM_max":95.63},{"x_label":"CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"CNS Embryonal tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005784","MONDO":"MONDO_0018843","GTEx_tissue_subgroup_UBERON":"","TPM_mean":21.01,"TPM_sd":29.71,"TPM_min":4.1,"TPM_25th_percentile":6.03,"TPM_median":9.69,"TPM_75th_percentile":14.99,"TPM_max":80.99},{"x_label":"Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 5)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000209","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.24,"TPM_sd":4.27,"TPM_min":3.23,"TPM_25th_percentile":4.98,"TPM_median":9.03,"TPM_75th_percentile":9.94,"TPM_max":14.03},{"x_label":"Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse intrinsic pontine glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.86,"TPM_sd":1.73,"TPM_min":5.52,"TPM_25th_percentile":5.97,"TPM_median":6.15,"TPM_75th_percentile":6.98,"TPM_max":10.2},{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 48)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":48,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.94,"TPM_sd":14.19,"TPM_min":1.69,"TPM_25th_percentile":4.96,"TPM_median":6.77,"TPM_75th_percentile":9.99,"TPM_max":79.59},{"x_label":"Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 8)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":8,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Dysembryoplastic neuroepithelial tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005551","MONDO":"MONDO_0005505","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.15,"TPM_sd":3.17,"TPM_min":3.64,"TPM_25th_percentile":7.74,"TPM_median":10.56,"TPM_75th_percentile":10.96,"TPM_max":12.71},{"x_label":"Embryonal tumor with multilayer rosettes  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 4)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Embryonal tumor with multilayer rosettes","GTEx_tissue_subgroup":"","EFO":"MONDO_0016715","MONDO":"MONDO_0016715","GTEx_tissue_subgroup_UBERON":"","TPM_mean":13.51,"TPM_sd":7.51,"TPM_min":6.05,"TPM_25th_percentile":10.44,"TPM_median":12,"TPM_75th_percentile":15.07,"TPM_max":23.96},{"x_label":"Ependymoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 47)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":47,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ependymoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000028","MONDO":"MONDO_0016698","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.98,"TPM_sd":2.74,"TPM_min":3.5,"TPM_25th_percentile":5.42,"TPM_median":6.17,"TPM_75th_percentile":7.72,"TPM_max":16.51},{"x_label":"Ewing sarcoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ewing sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000174","MONDO":"MONDO_0012817","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.65,"TPM_sd":4.48,"TPM_min":2.78,"TPM_25th_percentile":5.68,"TPM_median":8.58,"TPM_75th_percentile":10.09,"TPM_max":11.6},{"x_label":"Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":16,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ganglioglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0003094","MONDO":"MONDO_0016733","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.46,"TPM_sd":3.97,"TPM_min":2.14,"TPM_25th_percentile":5.57,"TPM_median":7.57,"TPM_75th_percentile":11.87,"TPM_max":14.42},{"x_label":"Glial-neuronal tumor NOS  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Glial-neuronal tumor NOS","GTEx_tissue_subgroup":"","EFO":"MONDO_0016729","MONDO":"MONDO_0016729","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.61,"TPM_sd":2.43,"TPM_min":3.5,"TPM_25th_percentile":4.58,"TPM_median":7.26,"TPM_75th_percentile":8.29,"TPM_max":9.34},{"x_label":"High-grade glioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 34)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":34,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"High-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0100342","MONDO":"MONDO_0100342","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.46,"TPM_sd":8.27,"TPM_min":2.2,"TPM_25th_percentile":5.31,"TPM_median":7.34,"TPM_75th_percentile":10.56,"TPM_max":49.95},{"x_label":"High-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":16,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"High-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016680","MONDO":"MONDO_0016680","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.72,"TPM_sd":5.62,"TPM_min":1.75,"TPM_25th_percentile":4.44,"TPM_median":6.86,"TPM_75th_percentile":10.84,"TPM_max":19.55},{"x_label":"Infant-type hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 4)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Infant-type hemispheric glioma","GTEx_tissue_subgroup":"","EFO":"EFO_0005543","MONDO":"MONDO_0014695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.81,"TPM_sd":1.11,"TPM_min":4.54,"TPM_25th_percentile":5.07,"TPM_median":5.92,"TPM_75th_percentile":6.66,"TPM_max":6.87},{"x_label":"Low-grade glioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 71)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":71,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Low-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0021637","MONDO":"MONDO_0021637","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.8,"TPM_sd":4.32,"TPM_min":2.24,"TPM_25th_percentile":5.4,"TPM_median":6.92,"TPM_75th_percentile":9.42,"TPM_max":33.58},{"x_label":"Low-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Low-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016685","MONDO":"MONDO_0016685","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.51,"TPM_sd":6.35,"TPM_min":2.83,"TPM_25th_percentile":5.74,"TPM_median":6.61,"TPM_75th_percentile":7.83,"TPM_max":24.92},{"x_label":"Malignant peripheral nerve sheath tumor  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Malignant peripheral nerve sheath tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0000760","MONDO":"MONDO_0017827","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.41,"TPM_sd":3.41,"TPM_min":3.82,"TPM_25th_percentile":5.82,"TPM_median":7.82,"TPM_75th_percentile":9.21,"TPM_max":10.6},{"x_label":"Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 31)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":31,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Medulloblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002939","MONDO":"MONDO_0007959","GTEx_tissue_subgroup_UBERON":"","TPM_mean":13.08,"TPM_sd":8.43,"TPM_min":2.36,"TPM_25th_percentile":7.74,"TPM_median":10.51,"TPM_75th_percentile":13.61,"TPM_max":38.87},{"x_label":"Meningioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 11)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":11,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Meningioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016642","MONDO":"MONDO_0016642","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.26,"TPM_sd":2.2,"TPM_min":0.3,"TPM_25th_percentile":4.06,"TPM_median":5.58,"TPM_75th_percentile":6.57,"TPM_max":8.03},{"x_label":"Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"All Cohorts","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.62,"TPM_sd":4.76,"TPM_min":3.34,"TPM_25th_percentile":8.02,"TPM_median":11.36,"TPM_75th_percentile":12.4,"TPM_max":19.43},{"x_label":"Neuroblastoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 5)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.21,"TPM_sd":3.76,"TPM_min":3.34,"TPM_25th_percentile":4.03,"TPM_median":6.94,"TPM_75th_percentile":9.35,"TPM_max":12.4},{"x_label":"Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Relapse Tumors, N = 8)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":8,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.76,"TPM_sd":4.15,"TPM_min":8.02,"TPM_25th_percentile":10.54,"TPM_median":11.94,"TPM_75th_percentile":14.48,"TPM_max":19.43},{"x_label":"Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Neurofibroma/Plexiform","GTEx_tissue_subgroup":"","EFO":"EFO_0000658","MONDO":"MONDO_0003304","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.01,"TPM_sd":2.51,"TPM_min":1.44,"TPM_25th_percentile":3.59,"TPM_median":5.17,"TPM_75th_percentile":6.36,"TPM_max":8.49},{"x_label":"Oligodendroglioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Oligodendroglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0000632","MONDO":"MONDO_0016695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.13,"TPM_sd":2.96,"TPM_min":4.79,"TPM_25th_percentile":7.36,"TPM_median":9.29,"TPM_75th_percentile":10.22,"TPM_max":13.56},{"x_label":"Pineoblastoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pineoblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000475","MONDO":"MONDO_0016722","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.05,"TPM_sd":6.59,"TPM_min":6.7,"TPM_25th_percentile":8.37,"TPM_median":10.04,"TPM_75th_percentile":14.72,"TPM_max":19.41},{"x_label":"Sarcoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 9)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":9,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.08,"TPM_sd":2.25,"TPM_min":1.93,"TPM_25th_percentile":2.31,"TPM_median":3.32,"TPM_75th_percentile":5.5,"TPM_max":7.84},{"x_label":"Schwannoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 4)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Schwannoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000693","MONDO":"MONDO_0002546","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.81,"TPM_sd":3.06,"TPM_min":2.17,"TPM_25th_percentile":4,"TPM_median":5.94,"TPM_75th_percentile":7.75,"TPM_max":9.17},{"x_label":"Teratoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Teratoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0002601","MONDO":"MONDO_0002601","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.76,"TPM_sd":2.08,"TPM_min":0.83,"TPM_25th_percentile":1.65,"TPM_median":2.47,"TPM_75th_percentile":3.72,"TPM_max":4.97},{"x_label":"Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Relapse Tumors, N = 5)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Wilms tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0006058","MONDO":"MONDO_0006058","GTEx_tissue_subgroup_UBERON":"","TPM_mean":14.26,"TPM_sd":5.58,"TPM_min":8.42,"TPM_25th_percentile":10.69,"TPM_median":13.4,"TPM_75th_percentile":15.9,"TPM_max":22.89},{"x_label":"Glioblastoma Multiforme  (Dataset = TCGA, Specimen = TCGA Relapse Tumors, N = 13)","specimen_descriptor_fill":"TCGA Relapse Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Glioblastoma Multiforme","GTEx_tissue_subgroup":"","EFO":"EFO_0000519","MONDO":"MONDO_0018177","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.94,"TPM_sd":2.97,"TPM_min":0.99,"TPM_25th_percentile":3.9,"TPM_median":4.34,"TPM_75th_percentile":4.9,"TPM_max":12.09},{"x_label":"Low-grade glioma  (Dataset = TCGA, Specimen = TCGA Relapse Tumors, N = 14)","specimen_descriptor_fill":"TCGA Relapse Tumors","box_sample_count":14,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Low-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0021637","MONDO":"MONDO_0021637","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.14,"TPM_sd":1.5,"TPM_min":1.41,"TPM_25th_percentile":3.3,"TPM_median":3.98,"TPM_75th_percentile":4.79,"TPM_max":7.19},{"x_label":"Ovarian Serous Cystadenocarcinoma  (Dataset = TCGA, Specimen = TCGA Relapse Tumors, N = 5)","specimen_descriptor_fill":"TCGA Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Ovarian Serous Cystadenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000043","MONDO":"MONDO_0006046","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.23,"TPM_sd":1.72,"TPM_min":1.63,"TPM_25th_percentile":3.39,"TPM_median":4.89,"TPM_75th_percentile":5.41,"TPM_max":5.84},{"x_label":"Sarcoma  (Dataset = TCGA, Specimen = TCGA Relapse Tumors, N = 3)","specimen_descriptor_fill":"TCGA Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.45,"TPM_sd":1.65,"TPM_min":2.79,"TPM_25th_percentile":3.63,"TPM_median":4.48,"TPM_75th_percentile":5.28,"TPM_max":6.08}]